NEW YORK, Nov 27 – French Proteomics company Proteus and CEA-LETI, part of the French Agency for Atomic Energy have announced a partnership to develop biochips for proteomic analysis, Proteus announced Nov 23.
The chip will use phenomics, a proprietary technology that allows researchers to access the entire proteome from a given genome or fragments of it. The process sorts each protein and maintains its function, preserving access to the corresponding genetic information, according to Proteus.
Currently, Proteus markets the phenomics technology in the form of a 96-well microteterplate. The new partnership will convert the technology into a group of over 8000 3cm microwell biochips. CEA-LETI, based in Grenoble, France, has already developed prototypes of electronic chips suited for molecular biology applications.The French government is providing funding to the partnership through its post genomic-sequencing program.